Enteric Softgel Capsules Market Research, 2032
The global enteric softgel capsules market was valued at $2.3 billion in 2022, and is projected to reach $3.5 billion by 2032, growing at a CAGR of 4% from 2023 to 2032.The surge in prevalence of nutritional deficiency diseases is a key driver for the growing demand in the enteric softgel capsule market. These capsules prove advantageous in delivering essential nutrients by bypassing the stomach and releasing in the intestine, optimizing absorption. Additionally, their ability to mask taste addresses issues related to the palatability of certain nutritional supplements, promoting greater patient compliance. As awareness of nutritional health rises, the demand for enteric softgel capsules continues to grow, driven by their efficacy in providing essential nutrients and also offering taste-masking benefits, thereby contributing to the market's expansion in response to evolving healthcare needs.
Key Takeaways
- On the basis of application, the health supplements segment dominated the enteric softgel capsules market size in terms of revenue in 2022 and is anticipated to grow at the fastest CAGR during the forecast period.
- On the basis of distribution channel, the pharmacy & drug store segment dominated the enteric softgel capsules market size in terms of revenue in 2022. However, the online provider segment is anticipated to grow at the fastest CAGR during the forecast period.
- Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
An enteric softgel capsule is an oral drug delivery system encapsulated in a gelatin-based shell designed to release its contents in the small intestine rather than the stomach. The gelatin shell, which may include glycerin and plasticizers, is flexible and easy to swallow. This specific formulation prevents the premature release of the encapsulated substance, making it suitable for drugs or supplements sensitive to gastric acids. Enteric softgel capsules are commonly utilized in the pharmaceutical and nutraceutical industries, offering benefits such as enhanced drug absorption, reduced gastrointestinal side effects, and improved patient compliance, especially for individuals with specific health considerations.
Market Dynamics
The enteric softgel capsules industry is experiencing growth propelled by technological advancements in manufacturing. Ongoing innovations enhance the efficiency and precision of softgel capsule production, contributing to improved quality and cost-effectiveness. Key industry players are actively focusing on developing advanced manufacturing methodologies, emphasizing automation and novel techniques. For instance, Catalent, Inc, offers OptiGel DR Softgel Technology, that has the capability to deliver an enteric release profile in a single-step manufacturing process without the need for coating. This commitment to technological progress not only boosts production capabilities but also ensures a competitive edge in the market. The growing synergy between technological advancements and the strategic initiatives of key players underscores a positive trajectory for the enteric softgel capsule market, fostering increased reliability and innovation in the manufacturing process.
In addition, the enteric softgel capsules industry is experiencing additional growth due to the increasing focus on clinical trials for new technologies and formulations. For instance, in October 2023, Evonik, a specialty chemicals leader, introduced EUDRACAP, a preclinical functional oral capsule. This enteric-coated capsule offers pharmaceutical companies a valuable tool in optimizing drug development during preclinical trials. By reducing costs, time, and variables, EUDRACAP enhances the efficiency of drug development processes. This innovative approach aligns with the industry's commitment to advancing methodologies, fostering a climate of continuous improvement and driving the market's growth through enhanced capabilities in clinical research and development.
Moreover, the continuous innovation in materials and polymers used in the manufacturing of enteric softgel capsules plays a significant role in driving market growth. Advancements in polymer science allow for the development of coatings that can withstand the acidic environment of the stomach and effectively release the contents in the intestine. This innovation contributes to the overall efficacy of enteric softgel capsules, making them more versatile for various pharmaceutical and nutraceutical applications. The exploration of alternative, sustainable, and plant-based materials also align with the growing emphasis on eco-friendly and vegetarian options, expanding the appeal of enteric softgel capsules in the market.
Furthermore, the rapid development of the e-commerce industry is acting as a catalyst for the growth of the enteric softgel capsule market. E-commerce platforms provide a convenient and accessible channel for the distribution of pharmaceutical and nutraceutical products, including enteric softgel capsules. This trend enables manufacturers to reach a broader consumer base, facilitating increased market penetration. Consumers can easily access a variety of health supplements online, contributing to the market's growth opportunities. The digital landscape enhances product visibility, eases the purchasing process, and supports the overall expansion of the enteric softgel capsule market through efficient online distribution and marketing strategies.
However, the enteric softgel capsules market growth is hindered by several factors. Limited applicability of enteric coatings to specific formulations restricts their use, affecting market expansion. Environmental concerns surrounding the use of gelatin, a common component of softgel capsules, may lead to shifts in consumer preferences towards eco-friendly alternatives. Additionally, the market faces intensified competition from generic products, heightening the pressure on pricing and market share. To thrive amid these challenges, strategic adaptation and innovation are imperative, addressing formulation limitations, exploring alternative materials, and navigating competitive dynamics to sustain growth in the enteric softgel capsule industry.
During a recession, the enteric softgel capsule market may experience both positive and negative impacts. On the positive side, there could be increased demand for pharmaceuticals and nutraceuticals as consumers focus on health and wellness. Enteric softgel capsules, known for their efficient drug delivery, may benefit from this heightened demand. However, negative effects may include reduced consumer spending on non-essential products, impacting the nutraceutical sector. Additionally, economic uncertainties could lead to a slowdown in pharmaceutical research and development, affecting the introduction of new products. Overall, the market's resilience may be tested, with potential shifts in demand influenced by economic conditions.
Segmental Overview
The enteric softgel capsules market is segmented on the basis of application, distribution channel, and region. On the basis of application, the market is segmented into health supplements and pharmaceuticals. On the basis of distribution channel, the market is segmented supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia,Argentina and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).
By Application
Depending on application, the market is segmented into health supplements and pharmaceuticals. The health supplements segment accounted for the largest share in terms of revenue in 2022 and is anticipated to register the fastest CAGR in the enteric softgel capsules market forecast period. This growth can be attributed to the increasing emphasis on preventive healthcare, a surge in fitness trends, and a proactive approach to well-being. In addition, consumers are progressively opting for health supplements to bridge nutritional gaps, boost immune function, and enhance overall vitality. As the interest in a healthy lifestyle and the adoption of personalized wellness solutions continue to rise, the demand for health supplements is expected to remain strong.
By Distribution Channel
Depending on distribution channel, the market is segmented into supermarkets & hypermarkets, pharmacy & drug stores, and online providers. The pharmacy & drug store segment accounted for the largest enteric softgel capsules market share in terms of revenue in 2022 and is expected to maintain its lead during the forecast period owing to its widespread accessibility, offering a convenient and trusted source for prescription medications, over-the-counter drugs, and various healthcare essentials. As essential healthcare providers, pharmacies play a crucial role in the healthcare ecosystem, providing essential services, medication counseling, and health advice. However, the online provider segment is expected to exhibit the fastest CAGR growth during the forecast period owing to the increasing reliance on online platforms for purchasing goods and services, including health-related products. The convenience of browsing, comparing, and purchasing health supplements and other products from the comfort of one's home, coupled with the availability of a wide range of choices, contributes to the sustained popularity of online providers.
By Region
Region wise, the Enteric Softgel Capsules market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America has the largest enteric softgel capsules market share in terms of revenue in 2022 and is expected to maintain its lead during the forecast period owing to a well-established healthcare infrastructure and high healthcare expenditure, supporting the demand for various health-related products and services. Additionally, the region experiences a consistently high level of awareness and emphasis on health and wellness among its population, driving the consumption of health supplements and related products. However, Asia-Pacific offers profitable enteric softgel capsules market opportunity, owing to surge in urbanization and changing dietary habits, leading to an increased focus on health and nutrition. As urban populations grow, there is a greater prevalence of sedentary lifestyles, creating a demand for supplements to compensate for potential nutritional deficiencies.
Competition Analysis
Competitive analysis and profiles of the major players in the enteric softgel capsules market that operate in the market, such as Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, and Procaps Group. The key players have adopted product launch as the key strategy to expand their product portfolio.
Recent Developments in the Enteric Softgel Capsules Market
In October 2020, Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the launch of OptiGel DR technology for the formulation and manufacture of delayed/enteric release softgels.
- In November 2022, Lonza, a preferred partner to the pharmaceutical, biotech and nutraceutical markets, launched an innovative new capsule solution for intestinal (enteric) drug delivery. The Capsugel Enprotect capsule does not disintegrate during stomach transit and only releases its contents in the intestine. Capsugel Enprotect capsules significantly simplify the drug product manufacturing process by mitigating the need for additional capsule coating or sealing.
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric softgel capsules market analysis from 2022 to 2032 to identify the prevailing enteric softgel capsules market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the enteric softgel capsules market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global enteric softgel capsules market trends, key players, market segments, application areas, and market growth strategies.
Enteric Softgel Capsules Market Report Highlights
| Aspects | Details |
 Market Size By 2032 | USD 3.5 billion |
 Growth Rate | CAGR of 4% |
 Forecast period | 2022 - 2032 |
 Report Pages | 250 |
 By Application |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Captek Softgel International Inc., aenova group, Gelita AG., Catalent, Inc., Fuji Capsules Co. Ltd., sirio pharma co., ltd., Viva Pharmaceuticals, Procaps Group, InovoBiologic Inc, NOW Foods Inc. |
Analyst Review
This section provides opinions that the key companies operating in the enteric softgel capsules market. The adoption of enteric softgel capsules is expected to increase due to rise in the number of self-directed consumers and upsurge in awareness about the availability of enteric softgel health supplements.
In addition, increase in R&D activities to develop enteric softgel capsules and rise in consumer awareness related to preventative healthcare are projected to supplement the market growth. Major advantages associated with the enteric softgel are higher bioavailability, better clinical outcome, and ease of use, which supplement the market growth. However, complications associated with the use of enteric softgel capsules, such as incompatibility with hygroscopic drugs and extracts, are expected to hinder the market growth.
Furthermore, North America is expected to remain dominant during the forecast period, due to surge in use of enteric softgel capsules. This is attributed to rise in healthcare awareness, ease of product accessibility, and higher adoption of omega-3 supplements. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players, due to surge in awareness toward preventative healthcare and rise in use of health supplements.
The total market value of enteric softgel capsule market is $2,338.99 million in 2022.
The forecast period for enteric softgel capsule market is 2023 to 2032
The market value of enteric softgel capsule market in 2032 is $3,469.25 million
The base year is 2022 in enteric softgel capsule market .
Top companies such as Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, Procaps Group. held a high market position in 2022. These key players held a high market postion owing to the strong geographical foothold in North America, Europe, Asia-Pacific, LA and MEA.
The health supplement segment is the most influencing segment in enteric softgel capsule market owing to growing emphasis on preventive healthcare, fitness trends, and a proactive approach to well-being. Consumers are increasingly turning to health supplements to address nutritional gaps, support immune function, and promote overall vitality.
The major factor that fuels the growth of the enteric softgel capsule market are growth in the pharmaceutical and nutraceutical industries, advancements in technology and formulation and rising investments in research and development drive the growth of the global enteric softgel capsule market.
Enteric softgel capsules represent pharmaceutical or nutraceutical formulations known for their soft, easily ingestible gelatinous exteriors. These capsules feature a specialized enteric coating, serving as a protective barrier against stomach acids and facilitating a controlled release in the intestine.
Loading Table Of Content...
Loading Research Methodology...
